Potent and highly selective neurokinin antagonists

EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma.

ESMO open·2026

The relative efficacy of multiple syringe tip disinfection techniques against virulent staphylococcus contamination.

The Journal of hospital infection·2024

Characterizing the molecular epidemiology of anaesthesia work area transmission of Staphylococcus aureus sequence type 5.

The Journal of hospital infection·2023

Transmission of Staphylococcus aureus in the anaesthesia work area has greater risk of association with development of surgical site infection when resistant to the prophylactic antibiotic administered for surgery.

The Journal of hospital infection·2023

Photon quantum entanglement in the MeV regime and its application in PET imaging.

Nature communications·2021

Pityriasis rubra pilaris-like erythroderma secondary to phosphoinositide 3-kinase inhibition.

Clinical and experimental dermatology·2018

Discovery of BBI-355, a Potent, Selective, and Orally Available Checkpoint Kinase 1 Inhibitor for the Treatment of Extrachromosomal DNA Oncogene-Amplified Cancers.

Journal of medicinal chemistry·2026

Structure-Guided Discovery of Novel Dual-Site FEM1B Ligands and Assessment of Their Use in Targeted Protein Degradation.

Journal of medicinal chemistry·2026

Targeting RNA-Binding Oncofetal Protein IGF2BP3: Discovery of Potent and Selective Inhibitors.

Journal of medicinal chemistry·2026

Circular Bivalent Aptamer Chimeras Leveraging LDLR-Mediated Lysosomal Shuttling for Targeted Protein Degradation.

Journal of medicinal chemistry·2026

The Mycobacterial cyt-bc1:aac3 Oxidase as a Drug Target: Activities of Arylvinylpiperazine Amides and Aminoquinazolines against Mycobacterium ulcerans.

Journal of medicinal chemistry·2026

Expanding Addressable KRAS Mutations through the Structure- and Property-Based Design of Dual-State (GDP/GTP), Reversible Pan-KRAS Inhibitors.

Journal of medicinal chemistry·2026

Discovery of Anti-Japanese Encephalitis Compounds: Based on Natural Compound Library, Bioinformatics, Network Pharmacology and Experimental Validation.

Current pharmaceutical design·2026

Steroids from Talaromyces stipitatus as potential hepatocellular carcinoma inhibitors: A computational study.

Molecular biology research communications·2026

AI-driven drug discovery using transformer-based molecular representation learning.

Frontiers in artificial intelligence·2026

Molecular and metabolic dysregulation of lung cancer in developing anti-tumor activity by gambogic acid mediated mTOR signaling: in vitro and computational study.

3 Biotech·2026

The Substitute Groups in FDA-Approved Small Molecule Drugs in 2020 - 2024.

Current medicinal chemistry·2026

Multi-Target Synergy of Coridius chinensis in Testicular Aging via Network Pharmacology-Metabolomics Integration.

Current medicinal chemistry·2026

Related Experiment Videos

Potent and highly selective neurokinin antagonists

Related Concept Videos

EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma.

The relative efficacy of multiple syringe tip disinfection techniques against virulent staphylococcus contamination.

Characterizing the molecular epidemiology of anaesthesia work area transmission of Staphylococcus aureus sequence type 5.

Transmission of Staphylococcus aureus in the anaesthesia work area has greater risk of association with development of surgical site infection when resistant to the prophylactic antibiotic administered for surgery.

Photon quantum entanglement in the MeV regime and its application in PET imaging.

Pityriasis rubra pilaris-like erythroderma secondary to phosphoinositide 3-kinase inhibition.

Discovery of BBI-355, a Potent, Selective, and Orally Available Checkpoint Kinase 1 Inhibitor for the Treatment of Extrachromosomal DNA Oncogene-Amplified Cancers.

Structure-Guided Discovery of Novel Dual-Site FEM1B Ligands and Assessment of Their Use in Targeted Protein Degradation.

Targeting RNA-Binding Oncofetal Protein IGF2BP3: Discovery of Potent and Selective Inhibitors.

Circular Bivalent Aptamer Chimeras Leveraging LDLR-Mediated Lysosomal Shuttling for Targeted Protein Degradation.

The Mycobacterial cyt-<i>bc</i><sub>1</sub><i>:aac<sub>3</sub></i> Oxidase as a Drug Target: Activities of Arylvinylpiperazine Amides and Aminoquinazolines against <i>Mycobacterium ulcerans</i>.

Expanding Addressable KRAS Mutations through the Structure- and Property-Based Design of Dual-State (GDP/GTP), Reversible Pan-KRAS Inhibitors.

Discovery of Anti-Japanese Encephalitis Compounds: Based on Natural Compound Library, Bioinformatics, Network Pharmacology and Experimental Validation.

Steroids from <i>Talaromyces stipitatus</i> as potential hepatocellular carcinoma inhibitors: A computational study.

AI-driven drug discovery using transformer-based molecular representation learning.

Molecular and metabolic dysregulation of lung cancer in developing anti-tumor activity by gambogic acid mediated mTOR signaling: in vitro and computational study.

The Substitute Groups in FDA-Approved Small Molecule Drugs in 2020 - 2024.

Multi-Target Synergy of Coridius chinensis in Testicular Aging via Network Pharmacology-Metabolomics Integration.

Related Experiment Videos

Potent and highly selective neurokinin antagonists

Related Concept Videos

Related Articles